These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy. Ueno R; Takase H; Suenaga J; Kishimoto M; Kurihara Y; Takei K; Kawahara N; Yamamoto T Exp Neurol; 2020 Jan; 323():113068. PubMed ID: 31629859 [TBL] [Abstract][Full Text] [Related]
3. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor. Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387 [TBL] [Abstract][Full Text] [Related]
4. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand. Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269 [TBL] [Abstract][Full Text] [Related]
5. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. Lee JK; Kim JE; Sivula M; Strittmatter SM J Neurosci; 2004 Jul; 24(27):6209-17. PubMed ID: 15240813 [TBL] [Abstract][Full Text] [Related]
6. LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice. Ito S; Nagoshi N; Tsuji O; Shibata S; Shinozaki M; Kawabata S; Kojima K; Yasutake K; Hirokawa T; Matsumoto M; Takei K; Nakamura M; Okano H eNeuro; 2018; 5(5):. PubMed ID: 30560203 [TBL] [Abstract][Full Text] [Related]
7. dl-3-n-butylphthalide promotes neuroplasticity and motor recovery in stroke rats. Sun Y; Cheng X; Wang H; Mu X; Liang Y; Luo Y; Qu H; Zhao C Behav Brain Res; 2017 Jun; 329():67-74. PubMed ID: 28442357 [TBL] [Abstract][Full Text] [Related]
8. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans. Kawakami Y; Saito Y; Nakagawa R; Kurihara Y; Takei K Neurosci Lett; 2018 Sep; 683():61-68. PubMed ID: 29953923 [TBL] [Abstract][Full Text] [Related]
9. Plexina2 and CRMP2 Signaling Complex Is Activated by Nogo-A-Liganded Ngr1 to Restrict Corticospinal Axon Sprouting after Trauma. Sekine Y; Algarate PT; Cafferty WBJ; Strittmatter SM J Neurosci; 2019 Apr; 39(17):3204-3216. PubMed ID: 30804090 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Nkcc1 promotes axonal growth and motor recovery in ischemic rats. Mu XP; Wang HB; Cheng X; Yang L; Sun XY; Qu HL; Zhao SS; Zhou ZK; Liu TT; Xiao T; Song B; Jolkkonen J; Zhao CS Neuroscience; 2017 Dec; 365():83-93. PubMed ID: 28964752 [TBL] [Abstract][Full Text] [Related]
11. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1. Kurihara Y; Arie Y; Iketani M; Ito H; Nishiyama K; Sato Y; Nakamura F; Mizuki N; Goshima Y; Takei K Biochem Biophys Res Commun; 2012 Feb; 418(2):390-5. PubMed ID: 22281491 [TBL] [Abstract][Full Text] [Related]
12. Constraint-induced movement therapy overcomes the intrinsic axonal growth-inhibitory signals in stroke rats. Zhao S; Zhao M; Xiao T; Jolkkonen J; Zhao C Stroke; 2013 Jun; 44(6):1698-705. PubMed ID: 23632976 [TBL] [Abstract][Full Text] [Related]
13. Axonal branching in lateral olfactory tract is promoted by Nogo signaling. Iketani M; Yokoyama T; Kurihara Y; Strittmatter SM; Goshima Y; Kawahara N; Takei K Sci Rep; 2016 Dec; 6():39586. PubMed ID: 28000762 [TBL] [Abstract][Full Text] [Related]
14. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Sato Y; Iketani M; Kurihara Y; Yamaguchi M; Yamashita N; Nakamura F; Arie Y; Kawasaki T; Hirata T; Abe T; Kiyonari H; Strittmatter SM; Goshima Y; Takei K Science; 2011 Aug; 333(6043):769-73. PubMed ID: 21817055 [TBL] [Abstract][Full Text] [Related]
16. Nogo receptor blockade overcomes remyelination failure after white matter stroke and stimulates functional recovery in aged mice. Sozmen EG; Rosenzweig S; Llorente IL; DiTullio DJ; Machnicki M; Vinters HV; Havton LA; Giger RJ; Hinman JD; Carmichael ST Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8453-E8462. PubMed ID: 27956620 [TBL] [Abstract][Full Text] [Related]
17. Blockade of Nogo-A/Nogo-66 receptor 1 (NgR1) Inhibits Autophagic Activation and Prevents Secondary Neuronal Damage in the Thalamus after Focal Cerebral Infarction in Hypertensive Rats. Xu W; Xiao P; Fan S; Chen Y; Huang W; Chen X; Liu G; Dang C; Zeng J; Xing S Neuroscience; 2020 Apr; 431():103-114. PubMed ID: 32068082 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation. Takahashi K; Takeuchi H; Kurihara Y; Doi H; Kunii M; Tanaka K; Nakamura H; Fukai R; Tomita-Katsumoto A; Tada M; Higashiyama Y; Joki H; Koyano S; Takei K; Tanaka F J Neuroinflammation; 2018 Feb; 15(1):46. PubMed ID: 29454354 [TBL] [Abstract][Full Text] [Related]
19. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury. Ito S; Nagoshi N; Kamata Y; Kojima K; Nori S; Matsumoto M; Takei K; Nakamura M; Okano H Stem Cell Reports; 2021 Nov; 16(11):2703-2717. PubMed ID: 34653401 [TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA Promotes Axonal Regeneration in Rats with Focal Cerebral Ischemia Through the Inhibition of Nogo-A/NgR1/RhoA/ROCKII/MLC Signaling. Wang J; Ni G; Liu Y; Han Y; Jia L; Wang Y Drug Des Devel Ther; 2020; 14():2775-2787. PubMed ID: 32764877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]